Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating an interleukin-11-associated or -mediated fibrotic disease or condition by administering an anti-interleukin-11 receptor subunit alpha (IL-11RA) antibody

Method of treating an interleukin-11-associated or -mediated fibrotic disease or condition by administering an anti-interleukin-11 receptor subunit alpha (IL-11RA) antibody

US Patent 12365738 · Granted Jul 22, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions comprising anti-NRP2 antibodies2025
Antibodies directed against interleukin 36 receptor (IL-36R)2025
Anti-IL-18BP antibodies2025
Anti-IL-18BP antibodies2025
Anti-IL-18BP antibodies2025
Anti-interleukin-11 receptor subunit α (IL-11Rα) antibodies2024
Anti-interleukin-11 receptor subunit α (IL-11Rα) antibodies2024
Anti-interleukin-11 receptor subunit α (IL-11Rα) antibodies2024
Compositions and methods comprising anti-NRP2 antibodies2024
Method of treating autoimmune disease with antibodies against IL-332024
Method of treating autoimmune disease with antibodies against IL-332024
Therapeutic compositions comprising anti-NRP2 antibodies2023